Terazocin Hydrochloride | CAS# 63074-08-8 | α1-adrenergic receptor

Terazocin Hydrochloride (anhydrous)

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 571341

CAS#: 63074-08-8

Description: Terazocin Hydrochloride is a potent and selective α1-adrenergic receptor that may induce decreased blood pressure and is used in the treatment of benign prostatic hyperplasia.

Chemical Structure

Terazocin Hydrochloride (anhydrous)

CAS# 63074-08-8

Instruction

Theoretical Analysis

MedKoo Cat#: 571341
Name: Terazocin Hydrochloride (anhydrous)
CAS#: 63074-08-8
Chemical Formula: C19H26ClN5O4
Exact Mass: 423.17
Molecular Weight: 423.900
Elemental Analysis: C, 53.84; H, 6.18; Cl, 8.36; N, 16.52; O, 15.10

Price and Availability

Size	Price	Availability	Quantity
100mg	USD 240
250mg	USD 500
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Terazocin HCl; Vasocard; Hyprin; A-45975; A 45975; A45975

IUPAC/Chemical Name: Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride

InChi Key: IWSWDOUXSCRCKW-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H25N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H

SMILES Code: O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 423.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: An GH, Kim MJ, Lee HJ, Park SS, Cho YW, Park K, Choa YH. Fabrication of terazocin-loaded poly(D,L-lactide) microspheres by an ultrasonic spray drying method and their release behaviors. J Nanosci Nanotechnol. 2008 Oct;8(10):5139-42. PubMed PMID: 19198407.

2: Liu G. [Effects of terazocin on hypertensive patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 1990 Oct;18(5):271-2. Chinese. PubMed PMID: 1982259.

3: Kotridis P, Kokkas B, Kyriakou P, Karamouzis M, Salpigidis G, Karantona C, Karadoumanis J, Ginis T, Goulis O, Papadopoulos PC, Vakalopoulos C, Sakantamis G, Dimitriadou A, Mirtsou-Fidani V, Papadopoulos CL. Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin. Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):143-6. PubMed PMID: 12877573.

4: Pawar A, Fahim M. Baroreceptor mediated blood pressure regulation is not affected during dose dependent inhibition of prostatic contractions by terazosin. Indian J Physiol Pharmacol. 2004 Oct;48(4):419-27. PubMed PMID: 15907050.

Your view history